SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Analyst upgrades, led by Goldman Sachs Buy rating on Palantirs sovereign-AI and customized-software opportunities, are a key focus alongside the stocks breakout to new highs. Bulls celebrate the momentum and speculate about a short squeeze, while skeptics point to the stretched valuation and risk of a pullback.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is being linked to Nasdaq-100 reentry and expected index-fund buying, alongside an NIH-backed effort to accelerate personalized cancer vaccines that traders see as supportive of its oncology program. Bulls point to the demand and cancer-vaccine prospects, while bears argue the move is detached from fundamentals and could fade after index-related buying subsides.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

NVAXs sharp rally is being linked to broader vaccine-sector strength after an NIH cancer-vaccine initiative lifted Moderna, while traders also focused on EU authorization of Sanofis Phase 3 COVID-flu combination trial and its potential milestone for Novavax. Many expect short-covering to amplify the move, but others question its durability and dismiss speculation about a Russian outbreak as unverified.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

SpaceXs planned acquisition of low-band spectrum has intensified concerns that Starlink could become a stronger competitor to AST SpaceMobile, contributing to a sharp selloff. Traders are divided: bears see a threat to ASTSs business, while bulls argue its carrier-partner model and access to operators spectrum remain differentiators; CEO Abel Avellan pushed back on the competitive concerns.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts launch of Microsoft-Decision-1, a specialized AI model for fast automated decisions, is drawing attention as shares push toward a record close. Traders are celebrating the breakout and AI momentum, while skeptics question whether the rally is justified and warn of an overextended valuation.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

Mosaic is drawing attention after a steep selloff to multi-year lows, with traders pointing to weak results, elevated sulfur costs, and the withdrawal of phosphate production guidance as pressures on its outlook. Some see the depressed valuation as a buying opportunity, while others fear further losses and question the companys ability to maintain its dividend.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Mercks partnership with Moderna on a personalized mRNA cancer vaccine is drawing attention after the Phase 3 melanoma trial met recurrence-free and distant metastasis-free survival endpoints alongside Keytruda. Traders are weighing the pipeline upside and potential to strengthen Mercks oncology franchise against uncertainty about the full data, overall-survival benefit, and how much optimism is already reflected in the shares.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers shares surged as traders revisited the potential peptide opportunity, including speculation about regulatory access, alongside a broader rally in biotech and pharma names. Bulls viewed the move as a possible breakout or short-covering rally, while skeptics saw another short-lived pop in the stocks prolonged trading range.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCXs sharp volatility is being tied to newly tradable shares after the lockup ended, with traders debating whether the added supply and a premium to estimated NAV justify further weakness. Bulls continue to treat the fund as a way to gain exposure to Anthropic and other private AI companies ahead of potential IPOs, while skeptics question its valuation and management.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflakes stronger-than-expected quarterly results and raised outlook, with AI demand cited as boosting data-platform consumption, drove a sharp rally and continued focus on the stock. Traders are divided between expecting further gains and warning that the valuation is stretched, with some pointing to profit-taking after the earnings surge.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DVYE  
ETF Overview 
The iShares Emerging Markets Dividend ETF (DVYE) tracks the Dow Jones Emerging Markets Select Dividend Index, which consists of approximately 100 high–dividend‑paying companies across emerging markets including a diversified mix across sectors like materials, energy, and financials . Its focus on dividend-paying firms tends to tilt toward lower‑volatility, income-generating equities, making it attractive for income‑focused investors seeking more stability than mainstream EM funds. 
 
Why You Might Want To Own $DVYE 
DVYE is well-suited for investors seeking high income from emerging markets while managing volatility. Its quarterly dividends and yield focus can provide attractive cash flow for income-generating portfolios.. If you&#39;re aiming to complement U.S. or global equity exposure with income and value-oriented EM stocks, DVYE provides a simple, passive vehicle. 
 
Disclosures - AAAMP Portfolios: Global Value (GV), Global Value Aggressive (GVA), Global High Income (GHI),

StockTwits Web

iShares Emerging Markets Dividend ETF

  
ETF Overview 
The iShares Emerging Markets Dividend ETF (DVYE) tracks the Dow Jones Emerging Markets Select Dividend Index, which consists of approximately 100 high–dividend‑paying companies across emerging markets including a diversified mix across sectors like materials, energy, and financials . Its focus on dividend-paying firms tends to tilt toward lower‑volatility, income-generating equities, making it attractive for income‑focused investors seeking more stability than mainstream EM funds. 
 
Why You Might Want To Own 

 
DVYE is well-suited for investors seeking high income from emerging markets while managing volatility. Its quarterly dividends and yield focus can provide attractive cash flow for income-generating portfolios.. If you're aiming to complement U.S. or global equity exposure with income and value-oriented EM stocks, DVYE provides a simple, passive vehicle. 
 
Disclosures - AAAMP Portfolios: Global Value (GV), Global Value Aggressive (GVA), Global High Income (GHI),